National service hotline
About Us
Company Profile

IPHASE Pharmaceutical Technology Co., a biopharmaceutical contract research and development institution located in China and the United States, integrating the drug research and development technology service platforms in China and the United States, based on AAALAC, GLP, CMA, CNAS (ISO/IEC 17025) and other laboratory certification, with experienced expert technical team, complete laboratory certification, complete analysis and detection instruments Standardized laboratory animal center and medical instrument operation platform; It is committed to providing global customers with safety evaluation and research services for analysis and detection, drug formation, effectiveness of medical devices, and chemicals, pesticides, new food raw materials and cosmetics

IPHASE Pharmaceutical Technology Co., Ltd. pursues“ Market-oriented, technical service market” And adhere to“ Honesty, preciseness, pragmatism, innovation” The company aims to provide domestic and foreign enterprises and scientific research institutions with high-quality products and services that represent the advanced technology level, and realize the brand commitment of Huizhi Taikang

Development History
Establish an analysis and detection technology platform with large instruments such as spectrum, chromatography and mass spectrometry.
Obtained CMA/CNAS (double C certification) qualification for the first time.
Obtained the high-tech enterprise certificate issued by the Beijing Municipal Commission of Science and Technology.
Establish an animal experiment technology platform in line with the GLP project, and obtain the Laboratory Animal Use License.
Obtained the Certificate of Good Laboratory Practice (GLP) compliance issued by China Certification and Accreditation Administration (CNCA).
It has passed the quality assessment of the National Health and Family Planning Commission and has been included in the chemical toxicity appraisal institution.
It has been fully certified by the "International Administrative Committee for the Evaluation and Accreditation of Experimental Animals AAALAC".
It has passed the accreditation and review of the public technology service platform in the new area of Beijing Economic and Technological Development Zone and obtained the certification of "comprehensive analysis and detection technology platform".
It was successfully selected as the 2018 Beijing Science and Technology Service Industry Promotion Project.
It was successfully selected as the 2018 Beijing Science and Technology Service Industry Promotion Project.
The company was officially awarded the "Public Service Platform for Small and Medium-sized Enterprises in Beijing".
Obtained the Beijing "Specialization and Innovation" SME Certificate issued by the Beijing Municipal Bureau of Economy and Information Technology.
In the field of biological analysis, CNAS-GLP certification can be used for compliance analysis and detection of various types of drug research.